Literature DB >> 2431754

Immunohistochemical studies of blood group substance H in colorectal tumors using a monoclonal antibody.

C Compton, R Wyatt, A Konugres, D Ehrenthal, P Durda.   

Abstract

With the use of a murine monoclonal antibody with specificity for human blood group substance H, the distribution of this antigen on colorectal carcinomas and adenomatous polyps has been studied by immunohistochemistry. All of the 20 carcinomas studied were found to express H substance regardless of their location in the colon, their pathologic grade, or their clinical stage. Adenomas were variably positive for H substance, and expression of the antigen appeared to correlate with the degree of dysplasia seen on microscopic examination. Normal colonic mucosa, nonadenomatous polyps, and nonepithelial colonic neoplasms studied failed to express H substance. The results suggest that detection of H substance expression may be useful in the diagnosis of colonic malignancies and dysplastic premalignant lesions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2431754     DOI: 10.1002/1097-0142(19870101)59:1<118::aid-cncr2820590125>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  The expression of colorectal carcinoma-associated antigens in the normal colonic mucosa. An immunohistochemical analysis of regional distribution.

Authors:  B C Wolf; R R Salem; H F Sears; D A Horst; P T Lavin; M Herlyn; S H Itzkowitz; J Schlom; G D Steele
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

2.  Regional distribution of glycoconjugates in normal, transitional and neoplastic human colonic mucosa. A histochemical study using lectins.

Authors:  J Calderó; E Campo; C Ascaso; J Ramos; M J Panadés; J M Reñé
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

3.  The recognition of cancer-associated fucosylated antigens in colorectal cancer by a novel monoclonal antibody, YB-2.

Authors:  H Naitoh; S Yazawa; T Asao; T Nakajima; J Nakamura; S Takenoshita; Y Nagamachi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.